CNBX Pharmaceuticals Inc. (CNBX)
About CNBX Pharmaceuticals Inc.
CNBX PHARMACEUTICAL INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$314.0K
- Total assets
- $18.4K
Source: SEC EDGAR · updated Jun 8, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
CNBX Pharmaceuticals Inc. (CNBX) Stock Price
- Reported a net loss of $314.0K in FY2025.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CNBX Pharmaceuticals Inc..
Write a review
CNBX Pharmaceuticals Inc.: frequently asked questions
Is CNBX Pharmaceuticals Inc. an American company?
CNBX Pharmaceuticals Inc. is a US-based company headquartered in Bethesda, Maryland, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is CNBX Pharmaceuticals Inc. headquartered?
CNBX Pharmaceuticals Inc. is headquartered in Bethesda, Maryland, United States.
Is CNBX Pharmaceuticals Inc. publicly traded?
Yes — CNBX Pharmaceuticals Inc. is a publicly traded company. Its stock trades under the ticker symbol CNBX on the OTC.
What does CNBX Pharmaceuticals Inc. do?
CNBX Pharmaceuticals Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
